Eden vs Mochi Health: Insurance-Support and Compounded Models

The Eden vs Mochi Health comparison turns on one structural difference: Mochi leans on insurance support, while Eden is a cash-pay compounded service. This PlexusDx Education Hub review contrasts those two models, their pricing, and the metabolic layer both leave out. Explore all Peptides & GLP-1 education.

Full head-to-head: PlexusDx vs Eden →

Independent editorial review: PlexusDx has no commercial relationship with Mochi Health, Eden, or their parent companies. No affiliate links or compensation are involved.

As of July 2026 the telehealth GLP-1 field holds dozens of programs. This piece stays with the two named here and the model difference that most affects the experience.

Mochi Health's insurance-support model

Mochi Health operates as telehealth with an insurance-support layer. Its GLP-1 track typically includes a virtual evaluation, a provider-issued prescription, and either brand-name FDA-approved dispensing or compounded semaglutide and tirzepatide through licensed pathways, with support aimed at working through coverage where possible. Current details sit on Mochi Health's website.

Eden's cash-pay compounded model

Eden runs as a telehealth-plus-compounded-pharmacy service on a cash-pay basis. It dispenses injectable compounded semaglutide and tirzepatide, bills monthly only, and charges nothing until a provider approves the prescription. Its structure is published on Eden's official website.

What insurance support does and does not change

An insurance-support model can matter when a branded GLP-1 is covered, but coverage for weight management is inconsistent and often excludes compounded products entirely. A cash-pay compounded service like Eden sidesteps insurance altogether with a fixed monthly figure. Which is better for you depends heavily on your plan's formulary, not on either brand's marketing.

Pricing, side by side

Eden advertises $99/month for compounded semaglutide and $199/month for tirzepatide, medication only, but a required Eden Membership ($99/month, disclosed in its own footnote) brings the all-in cost to $198/month for semaglutide and $298/month for tirzepatide, and it offers a money-back warranty tied to losing 10% of body weight in six months. Eden figures verified at checkout, July 2026. Mochi Health publishes its weight-loss pricing on its own site, where rates vary by medication and plan, so verify current Mochi Health pricing on its official site. For context, PlexusDx runs month-to-month at $189 for Semaglutide Injection and $289 for Tirzepatide Injection, with Semaglutide Oral at $289/month and Tirzepatide Oral at $349/month.

The evidence belongs to the compound

Coverage model aside, the pharmacology is the molecule's. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide were studied in STEP (semaglutide, NEJM 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Effect sizes vary by compound, dose, and population.

The genetic factor neither model measures

Whether a program bills insurance or cash, neither reads your inherited metabolic profile. MC4R, a melanocortin receptor central to satiety, and GLP1R, the receptor these compounds target, describe that biology as pathway-level context, not a response prediction. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights alongside the Weight Management Protocols so the profile and the plan are read together.

Not affiliated: PlexusDx is independent of both Mochi Health and Eden and has no commercial relationship with the companies reviewed above.

Related reading on PlexusDx: GLP 1 Receptor Agonist, GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1.

Disclaimer: This article is educational. PlexusDx is not affiliated with Mochi Health or Eden and offers semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare the PlexusDx approach: see the Weight Management Protocols for semaglutide and tirzepatide, or begin upstream with the Precision Peptide Genetic Test to map your GLP-1 pathway before you commit.

Frequently Asked Questions

Does Mochi Health's insurance support make it cheaper than Eden?

Not necessarily. Insurance support can help when a branded GLP-1 is covered, but weight-management coverage is inconsistent and compounded products are often excluded. Eden's cash-pay model gives a fixed monthly figure instead. The cheaper option depends on your specific plan, so check both against your formulary.

How does each program handle pricing?

Eden publishes specific numbers: a headline price plus a required membership that lifts the all-in cost to $198 or $298 per month (verified July 2026). Mochi Health publishes its pricing on its own site, where rates vary by medication and plan. Confirm current figures directly before enrolling.

Will insurance cover compounded GLP-1 medication?

Often it will not. Many plans exclude compounded formulations and cover only specific branded products under weight-management criteria. That is why a cash-pay compounded service can be predictable while an insurance-support model varies patient to patient. Verify with your own insurer before assuming coverage.

What does the Precision Peptide Genetic Test contribute?

It works upstream of either billing model. Rather than predicting response to a Mochi Health or Eden prescription, it reads pathway-level variants such as MC4R that describe your baseline GLP-1 and satiety biology, context that holds no matter how the medication is paid for.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education